X-Square Capital’s Array Biopharma Inc ARRY Stock Holding History

X-Square Capital’s Portfolio ARRY Stock Details ARRY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-200,421	Closed	-$4.89M	–	76
2019 Q1	$4.89M	Buy	200,421 +19,867	+11%	+$414K	3.35%	4
2018 Q4	$2.57M	Sell	180,554 -3,308	-2%	-$50.2K	2.02%	9
2018 Q3	$2.79M	Buy	183,862 +10,060	+6%	+$154K	1.85%	13
2018 Q2	$2.92M	Buy	173,802 +6,464	+4%	+$103K	2.19%	13
2018 Q1	$2.73M	Buy	167,338 +49,180	+42%	+$788K	2.88%	11
2017 Q4	$1.51M	Buy	+118,158	New	+$1.34M	1.59%	23

Other funds holding ARRY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

DKCM

Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

X-Square Capital's ARRY Position: Q2 2019 in Review

X-Square Capital sold out of Array Biopharma Inc (ARRY) in Q2 2019, closing a stake of 200,421 shares — an estimated $4.89M sold.

X-Square Capital first reported a position in ARRY in Q4 2017 and held it in 6 quarters. The position peaked at $4.89M in Q1 2019. 318 funds tracked by Wall St. Rank hold ARRY as of Q2 2019.

X-Square Capital reported no remaining Array Biopharma Inc position as of Q2 2019 after selling out during the quarter.
X-Square Capital sold 200,421 Array Biopharma Inc shares in Q2 2019, an estimated $4.89M.
X-Square Capital first reported a position in Array Biopharma Inc in Q4 2017 and held it in 6 quarters.
X-Square Capital's Array Biopharma Inc position peaked at $4.89M in Q1 2019.
318 funds tracked by Wall St. Rank held Array Biopharma Inc as of Q2 2019.

Based on X-Square Capital's 13F filing for Q2 2019, filed 14 Aug 2019.